CompletedNot Applicable

D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

Italy10 participantsStarted 2020-10-28

Plain-language summary

The aim of this pilot study is to test the effect of a 30 day-D-chiro-inositol oral treatment on a set of clinical parameters (mainly sex hormones) in a group of male volunteers selected by their age and BMI to investigate if D-chiro-inositol acts as an aromatase inhibitor.

Who can participate

Age range30 Years – 65 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Body mass index (BMI) range is between 22 and 34 kg/m2, in order to include subjects with normal weight, overweight and obese. Subjects with altered glycemia or hormonal status due to age or weight were enrolled in the study. Exclusion Criteria: * Men with poor general health were excluded from the study.

What they're measuring

Improvement of the Testosterone/Estradiol ratio in serum

Timeframe: Thirty days

Trial details

NCT IDNCT04615767

SponsorAGUNCO Obstetrics and Gynecology Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-06

View on ClinicalTrials.gov More Low Serum Testosterone Levels in Man trials